X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BPTH

Closed

Bio Path Holdings Inc

0.175
+0.005 (+2.94%)
Last Update: 01 Jul 2025 22:40:00
Yesterday: 0.17
Day's Range: 0.1605 - 0.175
Send
When Written:
 
1.39
Bio Path Holdings Inc. is a clinical-stage biotechnology company that develops targeted therapies for cancer. The company's lead product candidate, prexigebersen, is a targeted RNAi nanoparticle designed to inhibit the expression of the Grb2 protein, which is involved in cancer cell growth and survival pathways. Prexigebersen is being developed for the treatment of solid tumors, including pancreatic cancer, triple-negative breast cancer, and bladder cancer. Bio Path Holdings also has a pipeline of other RNAi nanoparticle drug candidates for the treatment of cancer and other diseases. The company was founded in 2007 and is headquartered in Bellaire, Texas.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X